UK markets closed

Esperion Therapeutics, Inc. (ESPR)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
1.9000-0.0900 (-4.52%)
At close: 04:00PM EDT
1.9000 0.00 (0.00%)
After hours: 07:38PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 359.86M
Enterprise value 543.78M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)1.68
Price/book (mrq)74.89
Enterprise value/revenue 4.67
Enterprise value/EBITDA -3.62

Trading information

Stock price history

Beta (5Y monthly) 0.82
52-week change 333.80%
S&P500 52-week change 322.36%
52-week high 33.4000
52-week low 30.7000
50-day moving average 32.4018
200-day moving average 31.7887

Share statistics

Avg vol (3-month) 36.22M
Avg vol (10-day) 35.49M
Shares outstanding 5189.4M
Implied shares outstanding 6202.72M
Float 8184.03M
% held by insiders 10.45%
% held by institutions 139.19%
Shares short (15 Apr 2024) 418.6M
Short ratio (15 Apr 2024) 41.95
Short % of float (15 Apr 2024) 49.85%
Short % of shares outstanding (15 Apr 2024) 49.82%
Shares short (prior month 15 Mar 2024) 417.67M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin -179.87%
Operating margin (ttm)-131.37%

Management effectiveness

Return on assets (ttm)-42.86%
Return on equity (ttm)N/A

Income statement

Revenue (ttm)116.33M
Revenue per share (ttm)1.13
Quarterly revenue growth (yoy)71.40%
Gross profit (ttm)N/A
EBITDA -155.4M
Net income avi to common (ttm)-209.25M
Diluted EPS (ttm)-2.0300
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)82.25M
Total cash per share (mrq)0.44
Total debt (mrq)540.95M
Total debt/equity (mrq)N/A
Current ratio (mrq)1.29
Book value per share (mrq)-3.85

Cash flow statement

Operating cash flow (ttm)-135.49M
Levered free cash flow (ttm)-107.14M